Phase 2 Regain Trial Crb3180015 Jrcts031190103 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase 2 regain trial crb3180015 jrcts031190103 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase 2 Regain Trial Crb3180015 Jrcts031190103 Today - Breaking & Trending Today

Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment

Second-line treatment with regorafenib displayed safety in patients with advanced hepatocellular carcinoma who were not eligible for treatment on the phase 3 RESORCE trial, according to data from the phase 2 REGAIN trial. ....

Comunidad Autonoma De Cataluna , Keisuke Koroki , School Of Medicine At Chiba University , Department Of Gastroenterology , International Liver Cancer Association Conference , Liver Cancer Association , Graduate School , Chiba University , Barcelona Clinic Liver Cancer , Hepatocellular Carcinoma , Phase 3 Resorce Trial Nct01774344 , Phase 2 Regain Trial Crb3180015 Jrcts031190103 ,